BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8767033)

  • 41. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
    Friedman J; Ault K; Powchik P
    Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prevalence of depressive symptoms in a population of ambulatory schizophrenics].
    Lempérière T; Rodière C; Rousselet N; Pilate C; Ades J; Lépine JP; Rouillon F
    Ann Med Psychol (Paris); 1983 Feb; 141(2):224-36. PubMed ID: 6137178
    [No Abstract]   [Full Text] [Related]  

  • 43. [Problems in evaluating new antipsychotic drugs].
    Fleischhacker WW
    Wien Med Wochenschr; 1998; 148(11-12):266-72. PubMed ID: 9746969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Syndromic and diagnostic heterogeneity of schizophrenia].
    Brazo P; Dollfus S
    Encephale; 1997 Apr; 23 Spec No 2():20-4. PubMed ID: 9273303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients.
    van Berckel BN; Hijman R; van der Linden JA; Westenberg HG; van Ree JM; Kahn RS
    Biol Psychiatry; 1996 Dec; 40(12):1298-300. PubMed ID: 8959296
    [No Abstract]   [Full Text] [Related]  

  • 46. Quetiapine has a direct effect on the negative symptoms of schizophrenia.
    Tandon R
    Hum Psychopharmacol; 2004 Dec; 19(8):559-63. PubMed ID: 15486960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response to Shen J, Kobak K, Zhao Y, et al. Use of remote centralized raters via live 2-way video ina multicenter clinical trial for schizophrenia. (J Clin Psychopharmacol. 2008;28:691-693).
    Grunze HC; Höschl C; Montgomery SA; Sartorius N; Vieta E
    J Clin Psychopharmacol; 2009 Aug; 29(4):409; author reply 409-10. PubMed ID: 19593194
    [No Abstract]   [Full Text] [Related]  

  • 48. Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms.
    Dávila R; Zumárraga M; Basterreche N; Arrúe A; Anguiano JB
    Psychiatry Res; 2007 May; 151(1-2):163-8. PubMed ID: 17434602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Do negative symptoms respond to pharmacological treatment?
    Kane JM; Mayerhoff D
    Br J Psychiatry Suppl; 1989 Nov; (7):115-8. PubMed ID: 2575914
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparing symptom response among antipsychotic medications in CATIE.
    Levine SZ; Rabinowitz J; Ascher-Svanum H; Faries DE; Lawson AH
    J Clin Psychopharmacol; 2013 Feb; 33(1):123-6. PubMed ID: 23288232
    [No Abstract]   [Full Text] [Related]  

  • 51. Depression measures and motor side-effects in patients with acute schizophrenia.
    Kontaxakis VP; Havaki-Kontaxaki BJ; Stamouli SS; Margariti MM; Kollias CT; Christodoulou GN
    Schizophr Res; 2002 Jul; 56(1-2):197-8. PubMed ID: 12084435
    [No Abstract]   [Full Text] [Related]  

  • 52. The relationship of the brief psychiatric rating scale to neuropsychological deficits in phenothiazine-treated schizophrenics.
    Golden CJ; Carpenter B; Wilkening G; Ruedrich S; Chu CC; Graber B
    Psychopharmacol Bull; 1983; 19(3):513-7. PubMed ID: 6138799
    [No Abstract]   [Full Text] [Related]  

  • 53. Information processing and maintenance dose requirements in schizophrenia.
    Marder SR; Asarnow RF; Van Putten T
    Psychopharmacol Bull; 1988; 24(2):247-50. PubMed ID: 2905506
    [No Abstract]   [Full Text] [Related]  

  • 54. Preliminary trial of clonidine treatment in two patients suffering from chronic schizophrenia.
    Elizur A; Levy A; Lahav M; Blum I
    Commun Psychopharmacol; 1980; 4(6):507-17. PubMed ID: 6117398
    [No Abstract]   [Full Text] [Related]  

  • 55. [Experiences with hemofiltration/hemodialysis in schizophrenias].
    Ernst K; Börner I; Herbst A; Klinkmann H; Lindenau K; Osten B; Precht K; Schläfke D; Seidel M
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():114-23. PubMed ID: 6130611
    [No Abstract]   [Full Text] [Related]  

  • 56. Apomorphine's antipsychotic activity.
    Schaffer MH; Davis JM; Tamminga CA
    Arch Gen Psychiatry; 1985 Sep; 42(9):927-8. PubMed ID: 2864035
    [No Abstract]   [Full Text] [Related]  

  • 57. Novel antipsychotics and negative symptoms.
    Möller HJ
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S43-7. PubMed ID: 9690970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positive and negative symptoms in schizophrenia: where are the data?
    de Leon J; Simpson GM; Peralta V
    Biol Psychiatry; 1992 Mar; 31(5):431-4. PubMed ID: 1349829
    [No Abstract]   [Full Text] [Related]  

  • 59. Symptoms of depression in schizophrenia.
    Murali T; Ravi Kumar S
    Indian J Med Res; 2008 Jun; 127(6):516-8. PubMed ID: 18765867
    [No Abstract]   [Full Text] [Related]  

  • 60. [Early detection and treatment of schizophrenia].
    Hasan A; Falkai P; Wobrock T
    MMW Fortschr Med; 2010 Mar; 152(9):53-5. PubMed ID: 20384099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.